|
|
Volumn 5, Issue , 2005, Pages
|
|
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: A case series
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEFACEPT;
CYCLOSPORIN;
DACLIZUMAB;
DICLOXACILLIN;
DOXEPIN;
EFALIZUMAB;
ETRETIN;
GLIBENCLAMIDE;
HYDROXYUREA;
HYDROXYZINE;
INFLIXIMAB;
LISINOPRIL;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
TIOGUANINE;
CD11 ANTIGEN;
IMMUNOLOGIC FACTOR;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MONOCLONAL ANTIBODY;
ADULT;
ARTICLE;
CASE REPORT;
CASE STUDY;
DIABETES MELLITUS;
DISEASE ACTIVITY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG RESPONSE;
ERYTHRODERMA;
FEMALE;
HEALTH CARE PERSONNEL;
HUMAN;
HYPERTENSION;
MALE;
NAUSEA;
NEPHROLITHIASIS;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
SKIN INFECTION;
ULTRAVIOLET B RADIATION;
IMMUNOLOGY;
MIDDLE AGED;
PATIENT COMPLIANCE;
PSORIASIS;
RECURRENT DISEASE;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD11;
ARTHRITIS, PSORIATIC;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PSORIASIS;
RECURRENCE;
|
|
EID: 27644598182
PISSN: 14715945
EISSN: 14715945
Source Type: Journal
DOI: 10.1186/1471-5945-5-9 Document Type: Article |
|
Times cited : (34)
|
|
References (4)
|
